Literature DB >> 11333927

Nasal-associated lymphoid tissue is a site of long-term virus-specific antibody production following respiratory virus infection of mice.

B Liang1, L Hyland, S Hou.   

Abstract

Nasal immunoglobulin A provides an initial defense against inhaled respiratory pathogens. However, it is not known whether the nasal-associated lymphoid tissues (NALT) are able to mount an effective long-lasting pathogen-specific immune response, nor is it known whether functional differences exist between the organized NALT (O-NALT) and the diffuse NALT lining the nasal passages (D-NALT). Here we show that although both the O-NALT and the D-NALT are capable of producing virus-specific antibody in response to influenza virus infection, the frequency of specific antibody-forming cells in the D-NALT is much greater than the frequency observed in the O-NALT. Furthermore, we show that the D-NALT but not the O-NALT is the site of long-term virus-specific humoral immunity which lasts for the life of the animal. These results indicate that the D-NALT is not only the major effector site of the NALT but also the site of local long-term specific antibody production.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11333927      PMCID: PMC114951          DOI: 10.1128/JVI.75.11.5416-5420.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

1.  Nasal immune system: distinctive Th0 and Th1/Th2 type environments in murine nasal-associated lymphoid tissues and nasal passage, respectively.

Authors:  T Hiroi; K Iwatani; H Iijima; S Kodama; M Yanagita; H Kiyono
Journal:  Eur J Immunol       Date:  1998-10       Impact factor: 5.532

2.  Nasal immunization with tetanus toxoid increases the subsequent systemic dimeric IgA1 antibody response to intramuscular immunization.

Authors:  F B Waldo
Journal:  J Clin Lab Immunol       Date:  1991-03

3.  Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.

Authors:  M L Clements; B R Murphy
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

4.  Effect of tonsillectomy and adenoidectomy on nasopharyngeal antibody response to poliovirus.

Authors:  P L Ogra
Journal:  N Engl J Med       Date:  1971-01-14       Impact factor: 91.245

5.  Influenza virus RNA in the lung and lymphoid tissue of immunologically intact and CD4-depleted mice.

Authors:  M C Eichelberger; M L Wang; W Allan; R G Webster; P C Doherty
Journal:  J Gen Virol       Date:  1991-07       Impact factor: 3.891

6.  Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit.

Authors:  H Y Wu; M W Russell
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

7.  Immunoglobulin A mediation of murine nasal anti-influenza virus immunity.

Authors:  K B Renegar; P A Small
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

Review 8.  The role of nasopharyngeal lymphoid tissue.

Authors:  C F Kuper; P J Koornstra; D M Hameleers; J Biewenga; B J Spit; A M Duijvestijn; P J van Breda Vriesman; T Sminia
Journal:  Immunol Today       Date:  1992-06

9.  Respiratory virus infection of mice provokes a permanent humoral immune response.

Authors:  L Hyland; M Sangster; R Sealy; C Coleclough
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

10.  Influenza virus-specific antibody-secreting cells in the murine lung during primary influenza virus infection.

Authors:  P D Jones; G L Ada
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

View more
  37 in total

1.  Enhanced influenza virus-like particle vaccines containing the extracellular domain of matrix protein 2 and a Toll-like receptor ligand.

Authors:  Bao-Zhong Wang; Harvinder S Gill; Sang-Moo Kang; Li Wang; Ying-Chun Wang; Elena V Vassilieva; Richard W Compans
Journal:  Clin Vaccine Immunol       Date:  2012-05-30

2.  Quantitative analysis of herpes simplex virus type 1-specific memory B cells generated by different routes of infection.

Authors:  Daisy J Vanitha; Hye Mee Joo; Barry T Rouse; Mark Y Sangster
Journal:  Virology       Date:  2006-11-17       Impact factor: 3.616

3.  Broad dispersion and lung localization of virus-specific memory B cells induced by influenza pneumonia.

Authors:  Hye Mee Joo; Yuxia He; Mark Y Sangster
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-25       Impact factor: 11.205

4.  Toll-like receptor 3 in nasal CD103+ dendritic cells is involved in immunoglobulin A production.

Authors:  H Takaki; S Kure; H Oshiumi; Y Sakoda; T Suzuki; A Ainai; H Hasegawa; M Matsumoto; T Seya
Journal:  Mucosal Immunol       Date:  2017-06-15       Impact factor: 7.313

5.  Nasal-associated lymphoid tissues (NALTs) support the recall but not priming of influenza virus-specific cytotoxic T cells.

Authors:  Angela Pizzolla; Zhongfang Wang; Joanna R Groom; Katherine Kedzierska; Andrew G Brooks; Patrick C Reading; Linda M Wakim
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-01       Impact factor: 11.205

6.  Influence of Plasma Cell Niche Factors on the Recruitment and Maintenance of IRF4hi Plasma Cells and Plasmablasts in Vaccinated, Simian Immunodeficiency Virus-Infected Rhesus Macaques with Low and High Viremia.

Authors:  Julia M Shaw; Leia K Miller-Novak; Venkatramanan Mohanram; Katherine McKinnon; Thorsten Demberg; Diego A Vargas-Inchaustegui; David Venzon; Marjorie Robert-Guroff
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

Review 7.  The development and function of mucosal lymphoid tissues: a balancing act with micro-organisms.

Authors:  T D Randall; R E Mebius
Journal:  Mucosal Immunol       Date:  2014-02-26       Impact factor: 7.313

8.  Inability to evoke a long-lasting protective immune response to respiratory syncytial virus infection in mice correlates with ineffective nasal antibody responses.

Authors:  Richard Singleton; Nathalie Etchart; Sam Hou; Lisa Hyland
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

9.  Local and systemic antibody responses in mice immunized intranasally with native and detergent-extracted outer membrane vesicles from Neisseria meningitidis.

Authors:  Terry Guthrie; Simon Y C Wong; Bin Liang; Lisa Hyland; Sam Hou; E Arne Høiby; Svein Rune Andersen
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

10.  Virus-neutralizing activity mediated by the Fab fragment of a hemagglutinin-specific antibody is sufficient for the resolution of influenza virus infection in SCID mice.

Authors:  Krystyna Mozdzanowska; Jingqi Feng; Walter Gerhard
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.